Clinical differences between hospitalized patients with COVID-19-related pneumonia and those with influenza-related pneumonia during the omicron variant surge
Table 2.
Pneumonia conditions and findings by group
|
|
|
COVID-19 pneumonia |
Flu pneumonia |
p value |
|
|
| Symptoms |
|
|
|
|
|
|
Fever |
30 (65.2%) |
6 (100%) |
0.082 |
|
|
Dyspnea |
11 (23.9%) |
3 (50.0%) |
0.175 |
|
|
Nausea, vomitting |
5 (10.9%) |
0 |
0.396 |
|
|
General malaise |
3 (6.5%) |
4 (66.7%) |
<0.001** |
|
|
Low conciousness |
2 (4.3%) |
0 |
0.602 |
|
|
Cough |
2 (4.3%) |
1 (2.2%) |
0.223 |
|
|
Palpitation |
1 (2.2%) |
0 |
0.715 |
|
|
None |
1 (2.2%) |
0 |
0.715 |
|
| Severity |
|
|
|
|
|
|
Mild |
9 (19.6%) |
2 (33.3%) |
0.474 |
|
|
Moderate |
31 (67.4%) |
2 (33.3%) |
0.103 |
|
|
Severe |
6 (13.4%) |
2 (33.3%) |
0.806 |
|
| Bacteria |
|
|
|
|
|
|
MSSA |
1 (2.2%) |
1 (16.7%) |
0.082 |
|
|
MSSA |
1 (2.2%) |
1 (16.7%) |
0.082 |
|
|
GAS |
0 |
1 (16.7%) |
0.005** |
|
|
MRCNS |
1 (2.2%) |
0 |
0.715 |
|
|
E coli |
1 (2.2%) |
0 |
0.715 |
|
|
Klebsiella spp |
1 (2.2%) |
0 |
0.715 |
|
| Aspiration pneumonia |
|
28 (28/46=60.9%) |
1 (1/6=16.7%) |
0.040* |
|
|
|
|
